PATENT CLAIM ANALYSIS

Application Number: 15880513
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["800", "018000"]

Abstract:
The present invention provides a transgenic mouse which comprises a deficiency for murine T lymphocytes, B lymphocytes and NK cells, a deficiency for murine MHC class I and MHC class II molecules, and a functional xenogenic SIRPα transgene. This mouse is useful for in vivo screening of various compounds, including immuno-therapeutic agents and vaccines. The said mouse is also useful for testing the in vivo metabolism of xenobiotic compounds.

Claim (Index 9):
The transgenic mouse of  claim 8 , wherein the HLA class I transgene is an HLA-A2 transgene and the HLA class II transgene is an HLA-DR1 transgene.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 86.0
- Lexical Diversity: 1.58333
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14388108', '15223879', '13847636', '12918676', '13551137']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6453801972191285
- 35 USC 102 Novelty (BERT): 0.62786387294783
- Combined Prediction Score: 0.6436285647919987
- Mean Citation Score: 386.186864
- Max Citation Score: 670.8642
- Similarity Product: 539.8368356699467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test